Suraksha Diagno.

{
  "main_header": {
    "sid": 10039467,
    "name": "Suraksha Diagno.",
    "stock_name": "Suraksha Diagno.",
    "full_name": "Suraksha Diagnostic Ltd",
    "name_url": "stocks-analysis/suraksha-diagno",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "261.55",
    "chg": -3.1,
    "chgp": "-1.17%",
    "dir": -1,
    "prev_price": "264.65",
    "mcapval": "1,355.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544293,
    "symbol": "SURAKSHA",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE877V01027",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "27.52 k",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/suraksha-diagno-10039467-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Suraksha Diagnostic Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-suraksha-diagnostic-ltd-fallingrising-3795071",
        "imagepath": "",
        "date": "2026-01-20 01:05:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Suraksha Diagnostic Ltd closed at ₹261.55 on 19 January, down by ₹3.10 or 1.17% from the previous session. This decline is part of a sustained four-day losing streak, during which the stock has fallen approximately 5.01%. This underperformance is notably sharper than the Sensex’s modest 0.75% decline over the same one-week period, signalling that the stock is facing pressures beyond general market weakness.</p>\n<p>The stock’s year-to-date return stands at -2.48%, slightly worse than the Sensex’s -2.32%, while its one-month performance shows a 4.26% loss compared to the benchmark’s 1.98% fall. Over the past year, Suraksha Diagnostic has experienced a significant 26.83% decline in share price, contrasting with the Sensex’s robust 8.65% g..."
      },
      {
        "title": "Suraksha Diagnostic Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suraksha-diagnostic-ltd-is-rated-hold-3788801",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SurakshaDiagnos_mojoScore_3788801.png",
        "date": "2026-01-11 10:10:27",
        "description": "Suraksha Diagnostic Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Suraksha Diagnostic Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suraksha-diagnostic-ltd-is-rated-hold-3776095",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SurakshaDiagnos_mojoScore_3776095.png",
        "date": "2025-12-31 10:10:03",
        "description": "Suraksha Diagnostic Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Suraksha Diagno. Sees Revision in Market Assessment Amidst Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suraksha-diagno-upgraded-from-sell-to-hold-by-marketsmojo-on-11-aug-2025-3764475",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SurakshaDiagno_mojoScore_3764475.png",
        "date": "2025-12-20 10:10:25",
        "description": "Suraksha Diagno., a small-cap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key financial and technical parameters. Despite ongoing challenges in stock performance, certain fundamental aspects have prompted a reassessment of the company’s standing among investors and analysts."
      },
      {
        "title": "Suraksha Diagno. Sees Revision in Market Evaluation Amidst Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suraksha-diagno-upgraded-from-sell-to-hold-by-marketsmojo-on-11-aug-2025-3736848",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SurakshaDiagno_mojoScore_3736848.png",
        "date": "2025-11-29 17:52:21",
        "description": "Suraksha Diagno., a small-cap player in the Healthcare Services sector, has recently undergone a revision in its market evaluation metrics, reflecting a nuanced shift in its financial and technical outlook. This adjustment highlights evolving perspectives on the company’s operational quality, valuation, financial trends, and technical positioning amid a challenging market environment."
      },
      {
        "title": "Are Suraksha Diagno. latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-suraksha-diagno-latest-results-good-or-bad-3690601",
        "imagepath": "",
        "date": "2025-11-11 19:44:38",
        "description": "Suraksha Diagnostic's latest financial results for Q2 FY26 present a mixed operational landscape. The company reported net sales of ₹78.73 crores, reflecting a year-on-year growth of 17.95% and a quarter-on-quarter increase of 8.46%. This marks the seventh consecutive quarter of revenue growth, indicating strong demand for its diagnostic services. However, the operational efficiency appears to be under pressure, as evidenced by a decline in net profit to ₹8.99 crores, which represents a year-on-year decrease of 13.06% and a quarter-on-quarter drop of 4.36%.\n\nThe operating margin has contracted significantly, falling to 30.62% from 34.74% in the same quarter last year, indicating a decline of 412 basis points. Similarly, the profit after tax (PAT) margin has decreased to 11.22%, down 400 basis points year-on-year. These margin compressions raise concerns about the sustainability of the company's growth model..."
      },
      {
        "title": "Suraksha Diagnostic Q2 FY26: Margin Pressure Overshadows Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/suraksha-diagnostic-q2-fy26-margin-pressure-overshadows-revenue-growth-3686869",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SurakshaDiagnos_quaterlyResult_3686869.png",
        "date": "2025-11-10 19:37:16",
        "description": "Suraksha Diagnostic Limited, a Kolkata-based healthcare diagnostics provider with a market capitalisation of ₹1,669 crores, reported consolidated net profit of ₹8.99 crores for Q2 FY26, declining 4.36% quarter-on-quarter and 13.06% year-on-year. Despite robust revenue growth of 17.95% YoY to ₹78.73 crores, the company witnessed significant margin compression as operating profit margin (excluding other income) contracted to 30.62% from 34.74% in the year-ago quarter. The stock traded at ₹323.90 on November 10, 2025, showing resilience with gains of 10.66% over the past month, though it remains 13.76% lower year-to-date."
      },
      {
        "title": "Why is Suraksha Diagno. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-suraksha-diagno-fallingrising-3642273",
        "imagepath": "",
        "date": "2025-10-24 00:16:25",
        "description": "As of 23-Oct, Suraksha Diagnostic Ltd's stock price is currently at 311.85, reflecting an increase of 1.8, or 0.58%. The stock has been on an upward trend, gaining for the last seven days with a total return of 8.83% during this period. It has outperformed its sector by 2.3% today. Additionally, the stock's performance over the past week shows a return of +5.44%, while it has underperformed over the past month with a return of -1.17%. The company maintains a low Debt to Equity ratio and has demonstrated healthy long-term growth, with operating profit increasing at an annual rate of 89.29%. Furthermore, high institutional holdings at 35.7% suggest strong investor confidence, contributing positively to the stock's recent performance.\n\nIn the broader market context, Suraksha Diagnostic Ltd's short-term performance of +5.44% over the past week significantly outpaces the Sensex, which has only increased by +1.30..."
      }
    ],
    "total": 89,
    "sid": "10039467",
    "stock_news_url": "https://www.marketsmojo.com/news/suraksha-diagnostic-10039467"
  },
  "announcements": [
    {
      "caption": "Intimation Regarding Change In Name Of Statutory Auditor Of The Company Pursuant To Conversion Into LLP",
      "datetime": "16-Jan-2026",
      "details": "The Statutory Auditor of the Company informed the Company about the change in the name of the audit firm from M S K A & Associates to M S K A & Associates LLP pursuant to conversion into a Limited Liability Partnership under the provisions of the Limited Liability Partnership Act 2008",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "12-Jan-2026",
      "details": "Compliance Certificate from our RTA i.e. KFin Technologies Limited under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "22-Dec-2025",
      "details": "Pursuant to provisions of SEBI(Prohibition of Insider Trading) Regulations 2015 and in terms of Companys Code of Conduct for regulating monitoring and reporting of trading by insiders the trading window for dealing in securities of the Company will remain closed for all designated person and their relatives from Thursday 01 January 2026 till 48 hours after the declaration of unaudited (standalone and consolidated) financial results of the Company for the quarter and nine months ended 31 December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Suraksha Diagnostic Ltd falling/rising?

2026-01-20 01:05:13

Recent Price Movement and Market Context

Suraksha Diagnostic Ltd closed at ₹261.55 on 19 January, down by ₹3.10 or 1.17% from the previous session. This decline is part of a sustained four-day losing streak, during which the stock has fallen approximately 5.01%. This underperformance is notably sharper than the Sensex’s modest 0.75% decline over the same one-week period, signalling that the stock is facing pressures beyond general market weakness.

The stock’s year-to-date return stands at -2.48%, slightly worse than the Sensex’s -2.32%, while its one-month performance shows a 4.26% loss compared to the benchmark’s 1.98% fall. Over the past year, Suraksha Diagnostic has experienced a significant 26.83% decline in share price, contrasting with the Sensex’s robust 8.65% g...

Read full news article

Suraksha Diagnostic Ltd is Rated Hold

2026-01-11 10:10:27

Suraksha Diagnostic Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Suraksha Diagnostic Ltd is Rated Hold

2025-12-31 10:10:03

Suraksha Diagnostic Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Suraksha Diagno. Sees Revision in Market Assessment Amidst Mixed Financial Signals

2025-12-20 10:10:25

Suraksha Diagno., a small-cap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key financial and technical parameters. Despite ongoing challenges in stock performance, certain fundamental aspects have prompted a reassessment of the company’s standing among investors and analysts.

Read full news article

Suraksha Diagno. Sees Revision in Market Evaluation Amidst Mixed Financial Signals

2025-11-29 17:52:21

Suraksha Diagno., a small-cap player in the Healthcare Services sector, has recently undergone a revision in its market evaluation metrics, reflecting a nuanced shift in its financial and technical outlook. This adjustment highlights evolving perspectives on the company’s operational quality, valuation, financial trends, and technical positioning amid a challenging market environment.

Read full news article

Are Suraksha Diagno. latest results good or bad?

2025-11-11 19:44:38

Suraksha Diagnostic's latest financial results for Q2 FY26 present a mixed operational landscape. The company reported net sales of ₹78.73 crores, reflecting a year-on-year growth of 17.95% and a quarter-on-quarter increase of 8.46%. This marks the seventh consecutive quarter of revenue growth, indicating strong demand for its diagnostic services. However, the operational efficiency appears to be under pressure, as evidenced by a decline in net profit to ₹8.99 crores, which represents a year-on-year decrease of 13.06% and a quarter-on-quarter drop of 4.36%. The operating margin has contracted significantly, falling to 30.62% from 34.74% in the same quarter last year, indicating a decline of 412 basis points. Similarly, the profit after tax (PAT) margin has decreased to 11.22%, down 400 basis points year-on-year. These margin compressions raise concerns about the sustainability of the company's growth model...

Read full news article

Suraksha Diagnostic Q2 FY26: Margin Pressure Overshadows Revenue Growth

2025-11-10 19:37:16

Suraksha Diagnostic Limited, a Kolkata-based healthcare diagnostics provider with a market capitalisation of ₹1,669 crores, reported consolidated net profit of ₹8.99 crores for Q2 FY26, declining 4.36% quarter-on-quarter and 13.06% year-on-year. Despite robust revenue growth of 17.95% YoY to ₹78.73 crores, the company witnessed significant margin compression as operating profit margin (excluding other income) contracted to 30.62% from 34.74% in the year-ago quarter. The stock traded at ₹323.90 on November 10, 2025, showing resilience with gains of 10.66% over the past month, though it remains 13.76% lower year-to-date.

Read full news article

Why is Suraksha Diagno. falling/rising?

2025-10-24 00:16:25

As of 23-Oct, Suraksha Diagnostic Ltd's stock price is currently at 311.85, reflecting an increase of 1.8, or 0.58%. The stock has been on an upward trend, gaining for the last seven days with a total return of 8.83% during this period. It has outperformed its sector by 2.3% today. Additionally, the stock's performance over the past week shows a return of +5.44%, while it has underperformed over the past month with a return of -1.17%. The company maintains a low Debt to Equity ratio and has demonstrated healthy long-term growth, with operating profit increasing at an annual rate of 89.29%. Furthermore, high institutional holdings at 35.7% suggest strong investor confidence, contributing positively to the stock's recent performance. In the broader market context, Suraksha Diagnostic Ltd's short-term performance of +5.44% over the past week significantly outpaces the Sensex, which has only increased by +1.30...

Read full news article

View All News